Filing Flows › Roivant Sciences (ROIV) › R&D spending
Roivant Sciences (ROIV) R&D spending by quarter
Roivant Sciences' R&D spending was $202M in Q1 FY27 (first quarter fiscal 2027), +22% from Q3 FY26. Over the last 6 quarters it ranged from $142M (Q3 FY25) to $202M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $202M | +22% | +32% |
| Q3 FY26 | $165M | +0.5% | +17% |
| Q2 FY26 | $165M | +8% | — |
| Q1 FY26 | $153M | +5% | — |
| Q4 FY25 | $145M | +3% | — |
| Q3 FY25 | $142M | — | — |
Q1 FY27 at a glance
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart follows the revenue to costs, profit and cash.
Questions
What is Roivant Sciences' R&D spending?
Roivant Sciences' R&D spending was $202M in Q1 FY27 (first quarter fiscal 2027), +22% from Q3 FY26.
How has Roivant Sciences' R&D spending changed?
Over the last 6 quarters it ranged from $142M (Q3 FY25) to $202M (Q1 FY27).